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Cancer is a complex and multifactorial group of di-
seases. Carcinogens, age, genetic predisposition, viral 
and bacterial infections, lifestyle and environment are 
highlighted among its factors associated.
Over the last few decades, the efforts of biomedical 
research in genomics and proteomics have focused on un-
derstanding the mechanisms which trigger cancer, inclu-
ding oral cancer. Despite the knowledge acquired so far, 
only 50% of our patients survive after 5 years1.
What happened with the clinical utility of molecular 
evidence? The study of the molecular characteristics of 
malignant neoplasms has sought to contribute to the cli-
nical management of cancer thus improving prognosis. 
In order to do this, recently, it has been sought to eva-
luate the benefit of integrating genomic and proteomic 
data (DNA copy number variation, DNA methylation 
and mRNA, microRNA and protein expression) from 
The Cancer Genome Atlas project2 with traditional cli-
nical variables for predicting survival of several types of 
cancer (kidney renal clear cell carcinoma, glioblastoma 
multiforme, ovarian serous cystadenocarcinoma and lung 
squamous cell carcinoma). The results are worrisome: 1) 
the information of clinical variables and molecular data 
are largely redundant in terms of survival 2) clinical va-
riables are the most informative resource for prognosis 
3) incorporating molecular data poorly increases without 
relevance the prediction models constructed from clini-
cal variables.
The number of cancer prognostic molecular markers in 
clinical use is pitifully small, despite decades of tremen-
dous and protracted efforts. Currently, many researchers 
make conclusions about the usefulness of the markers of 
interest by heavily relying on the p-value, rather than on 
the magnitude and uselfulness of registrying these mar-
kers in patients’ clinical outcomes (response to therapy, 
relapse, survival, etc.) Still, the assessments and analy-
sis are done on people who already have the disease and 
whose samples represent a profoundly altered biological 
system compared with a control group without the disea-
se. Because of these many details, there are no biomarkers 
for oral cancer yet and the therapeutic alternatives availa-
ble (surgery, radiation and chemotherapy) remain highly 
expensive and disfiguring3. Additionally, it may be more 
convenient for some areas of the pharmaceutical indus-
try to focus on studies which use pathological samples, 
highlighting the role of isolated potential therapeutic tar-
gets and using medication to keep patients chronic stable 
without triggering their death.
Even when the molecular study has not enhanced prog-
nosis in general, this could be highly relevant as far as 
predisposition to cancer concerns. It is known that early 
diagnosis of oral cancer is associated with high survival 
rates4. Therefore, if carcinogenesis is seen like an arrow 
from left to right, being placed leftmost of early diagnosis 
is even better.
It is necessary to define the actual state of susceptibili-
ty to the disease under a unifying concept: the “etiologic 
field effect”, which states that various etiological factors 
(exposome, including diet, lifestyle, environment, micro-
biota, genetic and hormonal factors) and their interac-
tions (interactome) contribute to form a tissue microen-
vironment which constitutes the “field of susceptibility” 
for neoplastic initiation, evolution and progression5.
Unfortunately, exposome is not informed when des-
cribing the population in a study, not even when it is 
a complementary file to a main text. If the clinical va-
riables are strongly related to the course of the disease, 
their registration should not be limited only to sex, age, 
TNM and whether there are smoking or drinking habits. 
The complexity of oral cancer deserves more than that, 
and the registration of variables must enable progress 
towards interactome and susceptibility status. What is 
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our patients’ nutritional status? Is there presence of phy-
siological stress? What is their immune system compe-
tition? Are there persistent infections? These questions 
should be answered when presenting a sample. Genomic 
and proteomic analysis can help to outline situations of 
biological normality, adaptation and, what concerns this 
letter, susceptibility. This will provide a panel of markers 
for population monitoring.
It is important to mention that the etiological fields 
are prior to acquiring the molecular aberrations that are 
considered to indicate the presence of a field canceriza-
tion. Therefore, the progress achieved at the beginning of 
the arrow will impact the current red numbers which are 
a testimony that there was much to be done but there are 
few alternatives already.
Clinical molecular research in areas of Oral Biology 
towards higher compression of the state of susceptibility 
to oral cancer is welcome but from a holistic point of view 
so that the pathology of systems synchronizes each of the 
chains and recorded items from the etiologic field.
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